Marshall Wace’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$191K Buy
62,057
+37,496
+153% +$115K ﹤0.01% 2322
2025
Q1
$47.4K Buy
24,561
+9,320
+61% +$18K ﹤0.01% 2398
2024
Q4
$57K Sell
15,241
-16,982
-53% -$63.5K ﹤0.01% 2305
2024
Q3
$158K Buy
32,223
+21,823
+210% +$107K ﹤0.01% 2155
2024
Q2
$78K Sell
10,400
-145,355
-93% -$1.09M ﹤0.01% 2194
2024
Q1
$3.87M Buy
+155,755
New +$3.87M 0.01% 969